image
Healthcare - Biotechnology - NASDAQ - US
$ 10.12
-11.5 %
$ 467 M
Market Cap
-3.27
P/E
BALANCE SHEET
286 M ASSETS
60.23%
295 M LIABILITIES
20.94%
-8.8 M EQUITY
86.50%
BALANCE SHEET DECOMPOSITION
Balance Sheet UroGen Pharma Ltd.
image
Current Assets 276 M
Cash & Short-Term Investments 237 M
Receivables 20.3 M
Other Current Assets 19.1 M
Non-Current Assets 9.58 M
Long-Term Investments 5.02 M
PP&E 3.79 M
Other Non-Current Assets 765 K
82.84 %7.11 %6.70 %Total Assets$285.7m
Current Liabilities 45.9 M
Accounts Payable 10.9 M
Short-Term Debt 0
Other Current Liabilities 35 M
Non-Current Liabilities 249 M
Long-Term Debt 122 M
Other Non-Current Liabilities 127 M
3.71 %11.89 %41.33 %43.06 %Total Liabilities$294.5m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 172.0 95.0 55.4 44.4 103.9 49.7 101.3 37.0 21.4 18.0 3.9 3.0
Short Term Investments 64.7 42.0 44.6 44.8 49.2 97.4 0 36.0 0 0 0 0
Receivables 20.3 15.4 12.7 11.7 7.0 0 0 0 83 K 0 0 0
Inventory 9.2 5.7 4.3 4.8 2.0 0 0 0.3 0.1 0 0 0
Other Current Assets 9.9 11.1 11.9 8.7 4.6 1.6 0.9 1.2 0.5 1.2 0.4 0.1
Total Current Assets 276.1 169.2 128.9 114.4 115.6 148.6 102.2 74.5 22.0 19.1 4.3 3.1
PP&E 3.8 2.4 3.7 3.1 4.2 4.7 0.9 0.8 0.7 0.3 71 K 77 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 5.0 4.5 0.2 0.7 1.9 48.6 51 K 29 K 24 K 0 0 0
Other Long Term Assets 0.8 2.3 2.7 1.5 0.3 0.5 0.3 0.2 0.2 0 0 0
Other Assets 0 0 0.6 0 0 0 0 0 0 0 0 0
Total Assets 285.7 178.3 136.2 119.7 122.0 202.4 103.6 75.5 23.1 19.4 4.4 3.2
LIABILITIES
Accounts Payable 10.9 6.5 5.5 5.8 3.3 4.7 4.3 2.8 1.9 1.7 0.5 0.3
Short Term Debt 0 0 0.9 0 0 0 0 0 0 0 0 0
Other Current Liabilities 35.0 24.7 17.4 16.6 18.2 14.8 9.2 3.5 1.3 0.5 0.4 0.1
Total Current Liabilities 45.9 31.2 23.9 22.4 21.4 19.5 13.5 7.0 3.1 2.2 0.9 0.5
Long Term Debt 121.7 99.4 99.1 0.4 1.5 2.6 0 0 0 0 0 0
Deferred Tax Income 0 0 3.0 2.8 2.7 0 0 0 0 0 0 0
Other Liabilities 126.8 112.9 101.9 88.6 2.7 0 0 0 3.6 0.9 0 0
Total Liabilities 294.5 243.5 225.0 111.3 25.6 22.1 13.5 7.0 6.7 3.1 0.9 0.5
EQUITY
Common Stock 0.1 89 K 63 K 61 K 60 K 57 K 44 K 37 K 6 K 6 K 2 K 2 K
Retained Earnings (806.2) (679.3) (577.1) (467.3) (356.5) (228.0) (122.9) (47.2) (27.2) (25.3) (12.6) (8.1)
Other Accumulative Comprehensive Income/Loss 56 K 12 K (0.1) 25 K 0.3 0.3 (0.7) (0.6) (0.4) (0.2) 0 0
Total Equity (8.8) (65.2) (88.7) 8.4 96.4 180.3 90.1 68.5 16.3 16.3 3.5 2.7
Total Liabilities and Equity 285.7 178.3 136.2 119.7 122.0 202.4 103.6 75.5 23.1 19.4 4.4 3.2
SHARES OUTSTANDING
Common Shares Outstanding 42.9 28.8 22.8 22.3 21.8 20.5 15.8 9.7 12.0 2.3 2.3 2.1